Our Company
Who We Are
We are a world-class team of scientists, drug developers, and manufacturing experts who are united in our shared goal of finding in vivo solutions to fulfill the promise of CAR T cell therapies for every patient in need.Â
Leadership
Board of Directors
Chairman of the Board
Co-founder & Chief Executive Officer
MPM Capital
Qiming Venture Partners USA
DCVC Bio
Co-founder & Managing Partner, Double Point Ventures
SoftBank
Scientific Advisory Board
Founder, Chief Scientific Officer, BrainChild Bio, Inc.
Fred Hutch Endowed Chair for Cell and Gene Therapy
Ben Towne Center for Childhood Cancer
Henry Pitot Professor of Pathology & Laboratory Medicine, University of Wisconsin, Madison
Current Investors
Together, we are advancing in vivo CAR T cell therapies to fulfill the promise of this treatment option to every patient in need. Learn more about our team of experts.
